Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.

B M NørgårdB MagnussenMichael Due LarsenS Friedman

Published in: Gut (2016)

This nationwide study is the largest to date, examining the effect of preconceptual paternal use of AZA/6-MP on birth outcomes in live born singletons. The results of no significantly increased risks of adverse birth outcomes are reassuring and support the continuation of paternal AZA/6-MP treatment during conception.

Keyphrases

gestational age
young adults
type diabetes
emergency department
pregnant women
pregnancy outcomes
climate change
low birth weight
combination therapy
glycemic control